372 related articles for article (PubMed ID: 17888730)
1. Rational design of Salmonella recombinant vaccines.
Cheminay C; Hensel M
Int J Med Microbiol; 2008 Jan; 298(1-2):87-98. PubMed ID: 17888730
[TBL] [Abstract][Full Text] [Related]
2. Rational design of Salmonella-based vaccination strategies.
Spreng S; Dietrich G; Weidinger G
Methods; 2006 Feb; 38(2):133-43. PubMed ID: 16414270
[TBL] [Abstract][Full Text] [Related]
3. Impact of vector-priming on the immunogenicity of a live recombinant Salmonella enterica serovar typhi Ty21a vaccine expressing urease A and B from Helicobacter pylori in human volunteers.
Metzger WG; Mansouri E; Kronawitter M; Diescher S; Soerensen M; Hurwitz R; Bumann D; Aebischer T; Von Specht BU; Meyer TF
Vaccine; 2004 Jun; 22(17-18):2273-7. PubMed ID: 15149786
[TBL] [Abstract][Full Text] [Related]
4. Stabilization of a plasmid coding for a heterologous antigen in Salmonella enterica serotype typhi vaccine strain CVD908-htrA by using site-specific recombination.
Stephens JC; Darsley MJ; Turner AK
Infect Immun; 2006 Jul; 74(7):4383-6. PubMed ID: 16790817
[TBL] [Abstract][Full Text] [Related]
5. M-01ZH09, an oral live attenuated Salmonella enterica serovar Typhi vaccine for the prevention of typhoid fever.
Jain SK
Curr Opin Mol Ther; 2009 Oct; 11(5):565-71. PubMed ID: 19806505
[TBL] [Abstract][Full Text] [Related]
6. Animal models paving the way for clinical trials of attenuated Salmonella enterica serovar Typhi live oral vaccines and live vectors.
Pasetti MF; Levine MM; Sztein MB
Vaccine; 2003 Jan; 21(5-6):401-18. PubMed ID: 12531639
[TBL] [Abstract][Full Text] [Related]
7. Attenuated Salmonella as live oral vaccines against typhoid fever and as live vectors.
Levine MM; Galen J; Barry E; Noriega F; Chatfield S; Sztein M; Dougan G; Tacket C
J Biotechnol; 1996 Jan; 44(1-3):193-6. PubMed ID: 8717403
[TBL] [Abstract][Full Text] [Related]
8. Attenuated Salmonella typhi and Shigella as live oral vaccines and as live vectors.
Levine MM; Galen J; Barry E; Noriega F; Tacket C; Sztein M; Chatfield S; Dougan G; Losonsky G; Kotloff K
Behring Inst Mitt; 1997 Feb; (98):120-3. PubMed ID: 9382732
[No Abstract] [Full Text] [Related]
9. Cloning, expression and characterization of heat shock protein 60 (groEL) of Salmonella enterica serovar Typhi and its role in protective immunity against lethal Salmonella infection in mice.
Paliwal PK; Bansal A; Sagi SS; Mustoori S; Govindaswamy I
Clin Immunol; 2008 Jan; 126(1):89-96. PubMed ID: 18024219
[TBL] [Abstract][Full Text] [Related]
10. Immune response variations to Salmonella enterica serovar Typhi recombinant porin proteins in mice.
Toobak H; Rasooli I; Talei D; Jahangiri A; Owlia P; Darvish Alipour Astaneh S
Biologicals; 2013 Jul; 41(4):224-30. PubMed ID: 23796754
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of phoP and rpoS mutants of Salmonella enterica serovar Typhi as attenuated typhoid vaccine candidates: virulence and protective immune responses in intranasally immunized mice.
Lee HY; Cho SA; Lee IS; Park JH; Seok SH; Baek MW; Kim DJ; Lee SH; Hur SJ; Ban SJ; Lee YK; Han YK; Cho YK; Park JH
FEMS Immunol Med Microbiol; 2007 Nov; 51(2):310-8. PubMed ID: 17725620
[TBL] [Abstract][Full Text] [Related]
12. Recent advances in the field of Salmonella Typhi vaccines.
Paterson GK; Maskell DJ
Hum Vaccin; 2010 May; 6(5):379-84. PubMed ID: 20534981
[TBL] [Abstract][Full Text] [Related]
13. [Characterization of attenuated Salmonella C500 strain with a delta asd mutant and use as an Asd+ balanced-lethal host-vector system].
Zhao Z; Xu Y; Wu B; Cheng X; Li Y; Tang X; Zhang C; Chen H
Sheng Wu Gong Cheng Xue Bao; 2009 Jan; 25(1):29-36. PubMed ID: 19441223
[TBL] [Abstract][Full Text] [Related]
14. Bacteremia associated with live attenuated chi8110 Salmonella enterica serovar Typhi ISP1820 in healthy adult volunteers.
Frey SE; Bollen W; Sizemore D; Campbell M; Curtiss R
Clin Immunol; 2001 Oct; 101(1):32-7. PubMed ID: 11580224
[TBL] [Abstract][Full Text] [Related]
15. Immunological, cellular and molecular events in typhoid fever.
Hamid N; Jain SK
Indian J Biochem Biophys; 2007 Oct; 44(5):320-30. PubMed ID: 18341207
[TBL] [Abstract][Full Text] [Related]
16. Safety and immunogenicity of attenuated Salmonella enterica serovar Typhimurium delivering an HIV-1 Gag antigen via the Salmonella Type III secretion system.
Kotton CN; Lankowski AJ; Scott N; Sisul D; Chen LM; Raschke K; Borders G; Boaz M; Spentzou A; Galán JE; Hohmann EL
Vaccine; 2006 Sep; 24(37-39):6216-24. PubMed ID: 16824652
[TBL] [Abstract][Full Text] [Related]
17. [Factors of Salmonella typhi virulence in relation to the development of new vaccines].
García JA; Paniagua J; Pelayo R; Isibasi A; Kumate J
Salud Publica Mex; 1992; 34(3):262-7. PubMed ID: 1615345
[TBL] [Abstract][Full Text] [Related]
18. Improvement of the live vaccine strain Salmonella enterica serovar Typhi Ty21a for antigen delivery via the hemolysin secretion system of Escherichia coli.
Hotz C; Fensterle J; Goebel W; Meyer SR; Kirchgraber G; Heisig M; Fürer A; Dietrich G; Rapp UR; Gentschev I
Int J Med Microbiol; 2009 Feb; 299(2):109-19. PubMed ID: 18706861
[TBL] [Abstract][Full Text] [Related]
19. Cell-mediated immunity and antibody responses elicited by attenuated Salmonella enterica Serovar Typhi strains used as live oral vaccines in humans.
Sztein MB
Clin Infect Dis; 2007 Jul; 45 Suppl 1():S15-9. PubMed ID: 17582562
[TBL] [Abstract][Full Text] [Related]
20. Safety and immunogenicity of an attenuated Salmonella enterica serovar Paratyphi A vaccine candidate.
Xiong K; Chen Z; Zhu C; Li J; Hu X; Rao X; Cong Y
Int J Med Microbiol; 2015 Sep; 305(6):563-71. PubMed ID: 26239100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
